(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | 46.48%10.4M | -56.03%5.1M | 18.15%31.9M | 30.43%9M | -32.26%4.2M | 1.43%7.1M | 68.12%11.6M | 50.00%27M | 38.08%6.9M | 2.41%6.2M |
Selling and administrative expenses | 46.48%10.4M | -56.03%5.1M | 18.15%31.9M | 30.43%9M | -32.26%4.2M | 1.43%7.1M | 68.12%11.6M | 50.00%27M | 38.08%6.9M | 2.41%6.2M |
-General and administrative expense | 46.48%10.4M | -56.03%5.1M | 18.15%31.9M | 30.43%9M | -32.26%4.2M | 1.43%7.1M | 68.12%11.6M | 50.00%27M | 38.08%6.9M | 2.41%6.2M |
Operating profit | -46.48%-10.4M | 56.03%-5.1M | -18.15%-31.9M | -30.43%-9M | 32.26%-4.2M | -1.43%-7.1M | -68.12%-11.6M | -50.00%-27M | -38.08%-6.9M | -2.41%-6.2M |
Net non-operating interest income (expenses) | 161.11%1.1M | 40.00%1.4M | 118.18%200K | 100.00%1M | 0 | -157.14%-1.8M | 183.33%1M | 93.96%-1.1M | 125.29%500K | 105.78%300K |
Non-operating interest income | 26.32%2.4M | 68.75%2.7M | 225.00%7.8M | 107.69%2.7M | 60.00%1.6M | 1,800.00%1.9M | --1.6M | 2,300.00%2.4M | 9,185.71%1.3M | 2,027.66%1M |
Non-operating interest expense | -64.86%1.3M | 116.67%1.3M | 117.14%7.6M | 112.50%1.7M | 128.57%1.6M | 362.50%3.7M | -50.00%600K | -80.87%3.5M | -59.82%800K | -86.63%700K |
Other net income (expenses) | -91.62%9.7M | -77.85%7.2M | 468.94%118.8M | 54.01%-80.8M | -32.85%51.3M | 764.18%115.8M | -39.48%32.5M | -114.19%-32.2M | -384.01%-175.7M | 9.54%76.4M |
Special income (charges) | --0 | ---- | 63.54%-62.2M | --0 | --0 | ---62.2M | ---- | ---170.6M | ---170.6M | --0 |
-Less:Impairment of capital assets | --0 | ---- | -63.54%62.2M | --0 | --0 | --62.2M | ---- | --170.6M | --170.6M | --0 |
Income before tax | -99.63%400K | -84.02%3.5M | 244.44%87.1M | 51.24%-88.8M | -33.19%47.1M | 1,775.44%106.9M | -51.97%21.9M | -131.62%-60.3M | -431.75%-182.1M | 20.50%70.5M |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | -99.63%400K | -84.02%3.5M | 244.44%87.1M | 51.24%-88.8M | -33.19%47.1M | 1,775.44%106.9M | -51.97%21.9M | -131.62%-60.3M | -431.75%-182.1M | 20.50%70.5M |
Net income continuous operations | -99.63%400K | -84.02%3.5M | 244.44%87.1M | 51.24%-88.8M | -33.19%47.1M | 1,775.44%106.9M | -51.97%21.9M | -131.62%-60.3M | -431.75%-182.1M | 20.50%70.5M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -99.63%400K | -84.02%3.5M | 244.44%87.1M | 51.24%-88.8M | -33.19%47.1M | 1,775.44%106.9M | -51.97%21.9M | -131.62%-60.3M | -431.75%-182.1M | 20.50%70.5M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -99.63%400K | -84.02%3.5M | 244.44%87.1M | 51.24%-88.8M | -33.19%47.1M | 1,775.44%106.9M | -51.97%21.9M | -131.62%-60.3M | -431.75%-182.1M | 20.50%70.5M |
Diluted earnings per share | -99.61%0.0009 | -80.00%0.01 | 246.15%0.19 | 51.28%-0.19 | -33.33%0.1 | 2,200.00%0.23 | -50.00%0.05 | -132.50%-0.13 | -454.55%-0.39 | 25.00%0.15 |
Basic earnings per share | -99.63%0.0009 | -80.00%0.01 | 238.46%0.18 | 51.28%-0.19 | -28.57%0.1 | 2,200.00%0.23 | -44.44%0.05 | -132.50%-0.13 | -454.55%-0.39 | 16.67%0.14 |
Dividend per share | 0 | 0.00%0.025 | 0.00%0.05 | 0 | 0.00%0.025 | 0 | 0.00%0.025 | 0.05 | 0 | 0.025 |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.